CVS · NYSE · Medical - Healthcare Plans

CVS Health (CVS)

Combines health insurance, pharmacy benefits, retail pharmacies, and care delivery across the United States.

$87.08
After hours−0.01 (−0.01%)
At close$87.09(−0.58%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue89,76493,81388,43791,23495,42897,71094,58898,915102,871105,693100,426106,096
Cost of revenue76,18779,93775,87677,85182,87084,81180,19285,32289,06592,12684,80290,347
Gross profit13,57713,87612,56113,38312,55812,89914,39613,59313,80613,56715,62415,749
9,88710,50310,29010,33811,72610,53111,02211,21217,01311,45510,94411,046
Other expenses9,88710,50310,29010,33811,72610,53111,02211,21217,01311,45510,94411,046
Operating income3,6903,3732,2713,0458322,3683,3742,381−3,2072,1124,6804,703
−671−668−691−708−727−242−757−734−275−758−742−726
Interest expense693690716732752758785763784787774757
Other non-operating income−22−22−25−24−25−512−28−29−509−29−32−31
Income before tax3,0192,7051,5802,3371052,1262,6171,647−3,4821,3543,9383,977
Income tax expense75465845656934503835634508−1,569995982
Net income from continuing operations2,2652,0471,1241,768711,6231,7821,013−3,9902,9232,9432,995
Net income2,2612,0461,1131,770871,6441,7791,021−3,9752,9432,9432,995
EPS, basic$1.76$1.59$0.88$1.41$0.07$1.31$1.41$0.81−$3.13$2.32$2.31$2.33
EPS, diluted$1.75$1.59$0.88$1.41$0.07$1.30$1.41$0.80−$3.13$2.30$2.30$2.31
Weighted average shares, basic1,2871,2881,2601,2561,2591,2591,2611,2661,2691,2701,2731,276
Weighted average shares, diluted1,2901,2931,2671,2591,2591,2611,2641,2701,2691,2771,2791,283
EBITDA4,8394,5293,4344,2202,0184,0274,5563,581−1,5643,2885,8275,860
Depreciation & amortization1,1271,1341,1381,1511,1611,1471,1541,1711,1341,1471,1151,126
EBIT3,7123,3952,2963,0698572,8803,4022,410−2,6982,1414,7124,734